Inhalable Drugs Market 2020-2026
Inhalable Drugs Market 2020-2026
Abstract
Global Inhalable Drugs Market Size, Share & Trends Analysis Report by Application (Respiratory Diseases and Non-Respiratory Diseases), By Route of Administration (Nasal and Mouth), and Forecast 2020-2026
The global inhalable drug market is anticipated to grow at a CAGR of 3.7% during the forecast period (2020-2026). The key factors that drive the growth of the market include the high prevalence of respiratory diseases as well as non-respiratory diseases across the globe. Besides, inhalable drugs are also easy in handling and convenient in use in comparison with oral medicines, due to which, these are highly preferred amongst the people who find it difficult to swallow or inject drugs. Novel product launches by the players and continuous innovation in the existing products further drive the growth of the inhalable drug market over the forecast period.
The global inhalable drug market has been segmented on the basis of the application and route of administration. Based on the application, the market is bifurcated into respiratory disease and non-respiratory diseases. The respiratory disease segment is likely to hold a significant share over the forecast period. Based on the route of administration, the market is segmented into the nasal inhalable drug and mouth inhalable drugs. The mouth segment is likely to contribute a significant share over the forecast period.
Geographically, the study of the global inhalable drug market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and the Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Asia-Pacific is estimated to grow significantly during the forecast period. Further, Boehringer Ingelheim International GmbH, Pfizer Inc., Novartis International AG, AstraZeneca Plc, GlaxoSmithKline Plc, Johnson & Johnson Services Inc., Bausch Health Companies Inc., and TFF Pharmaceuticals, Inc. are some of the players covered in the global inhalable drugs market report.
Research Methodology
The market study of the global inhalable drugs market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary Sources Include:
• Financial reports of companies involved in the market
• Whitepapers, research-papers, and news blogs
• Company websites and their product catalog
The report is intended for pharmaceutical companies, drug manufacturers, research institutes, government organizations, regulatory bodies, industry associates & experts, other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.
Market Segmentation
1. Global Inhalable Drugs Market Research and Analysis by Application
2. Global Inhalable Drugs Market Research and Analysis by Route of Administration
The Report Covers
• Comprehensive Research Methodology of the global Inhalable Drugs market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global Inhalable Drugs market.
• Insights about market determinants which are stimulating the global Inhalable Drugs market.
• Detailed and extensive market segments with regional distribution of forecast revenues.
• Extensive profiles and recent developments of the market players.
Content
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Boehringer Ingelheim International GmbH
3.1.1.1. Overview
3.1.1.2. Financial Analysis
3.1.1.3. SWOT Analysis
3.1.1.4. Recent Developments
3.1.2. GlaxoSmithKline Plc
3.1.2.1. Overview
3.1.2.2. Financial Analysis
3.1.2.3. SWOT Analysis
3.1.2.4. Recent Developments
3.1.3. Pfizer Inc.
3.1.3.1. Overview
3.1.3.2. Financial Analysis
3.1.3.3. SWOT Analysis
3.1.3.4. Recent Developments
3.1.4. NovartisInternational AG
3.1.4.1. Overview
3.1.4.2. Financial Analysis
3.1.4.3. SWOT Analysis
3.1.4.4. Recent Developments
3.1.5. AstraZeneca Plc
3.1.5.1. Overview
3.1.5.2. Financial Analysis
3.1.5.3. SWOT Analysis
3.1.5.4. Recent Developments
3.2. Key Strategy Analysis
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Inhalable Drugs Market by Applications
5.1.1. Respiratory Diseases
5.1.2. Non-RespiratoryDiseases
5.2. Global Inhalable Drugs Market by Route of Administration
5.2.1. Nasal
5.2.2. Mouth
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. AptarGroup, Inc.
7.2. AstraZeneca Plc
7.3. Bausch Health Companies Inc.
7.4. Boehringer Ingelheim International GmbH
7.5. Cipla Ltd.
7.6. F. Hoffmann-La Roche Ltd.
7.7. GlaxoSmithKline Plc
7.8. Johnson & Johnson Services Inc.
7.9. Medisol Lifescience Pvt. Ltd.
7.10. Merck & Co., Inc.
7.11. Mylan NV
7.12. Novartis International AG
7.13. Pfizer Inc.
7.14. Sanofi SA
7.15. Sumitomo Dainippon Pharma Co. Ltd.
7.16. Teicos Pharma Ltd.
7.17. Teva Pharmaceutical Industries Ltd.
7.18. TFF Pharmaceuticals, Inc.
7.19. Vectura Group Plc
7.20. Verona Pharma plc
7.21. Zambon S.p.A.
List of Tables
1. GLOBAL INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
2. GLOBAL INHALABLE DRUGS FOR RESPIRATORY DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
3. GLOBAL INHALABLE DRUGS FOR NON-RESPIRATORY DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
4. GLOBAL INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
5. GLOBAL NASAL INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
6. GLOBAL MOUTH INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
7. GLOBAL INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
8. NORTH AMERICAN INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
9. NORTH AMERICAN INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
10. NORTH AMERICAN INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
1
List of Tables
1. EUROPEAN INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
12. EUROPEAN INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
13. EUROPEAN INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
14. ASIA-PACIFIC INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
15. ASIA-PACIFIC INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
16. ASIA-PACIFIC INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
17. REST OF THE WORLD INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
18. REST OF THE WORLD INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
The global inhalable drug market is anticipated to grow at a CAGR of 3.7% during the forecast period (2020-2026). The key factors that drive the growth of the market include the high prevalence of respiratory diseases as well as non-respiratory diseases across the globe. Besides, inhalable drugs are also easy in handling and convenient in use in comparison with oral medicines, due to which, these are highly preferred amongst the people who find it difficult to swallow or inject drugs. Novel product launches by the players and continuous innovation in the existing products further drive the growth of the inhalable drug market over the forecast period.
The global inhalable drug market has been segmented on the basis of the application and route of administration. Based on the application, the market is bifurcated into respiratory disease and non-respiratory diseases. The respiratory disease segment is likely to hold a significant share over the forecast period. Based on the route of administration, the market is segmented into the nasal inhalable drug and mouth inhalable drugs. The mouth segment is likely to contribute a significant share over the forecast period.
Geographically, the study of the global inhalable drug market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and the Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Asia-Pacific is estimated to grow significantly during the forecast period. Further, Boehringer Ingelheim International GmbH, Pfizer Inc., Novartis International AG, AstraZeneca Plc, GlaxoSmithKline Plc, Johnson & Johnson Services Inc., Bausch Health Companies Inc., and TFF Pharmaceuticals, Inc. are some of the players covered in the global inhalable drugs market report.
Research Methodology
The market study of the global inhalable drugs market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary Sources Include:
• Financial reports of companies involved in the market
• Whitepapers, research-papers, and news blogs
• Company websites and their product catalog
The report is intended for pharmaceutical companies, drug manufacturers, research institutes, government organizations, regulatory bodies, industry associates & experts, other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.
Market Segmentation
1. Global Inhalable Drugs Market Research and Analysis by Application
2. Global Inhalable Drugs Market Research and Analysis by Route of Administration
The Report Covers
• Comprehensive Research Methodology of the global Inhalable Drugs market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global Inhalable Drugs market.
• Insights about market determinants which are stimulating the global Inhalable Drugs market.
• Detailed and extensive market segments with regional distribution of forecast revenues.
• Extensive profiles and recent developments of the market players.
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Boehringer Ingelheim International GmbH
3.1.1.1. Overview
3.1.1.2. Financial Analysis
3.1.1.3. SWOT Analysis
3.1.1.4. Recent Developments
3.1.2. GlaxoSmithKline Plc
3.1.2.1. Overview
3.1.2.2. Financial Analysis
3.1.2.3. SWOT Analysis
3.1.2.4. Recent Developments
3.1.3. Pfizer Inc.
3.1.3.1. Overview
3.1.3.2. Financial Analysis
3.1.3.3. SWOT Analysis
3.1.3.4. Recent Developments
3.1.4. NovartisInternational AG
3.1.4.1. Overview
3.1.4.2. Financial Analysis
3.1.4.3. SWOT Analysis
3.1.4.4. Recent Developments
3.1.5. AstraZeneca Plc
3.1.5.1. Overview
3.1.5.2. Financial Analysis
3.1.5.3. SWOT Analysis
3.1.5.4. Recent Developments
3.2. Key Strategy Analysis
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Inhalable Drugs Market by Applications
5.1.1. Respiratory Diseases
5.1.2. Non-RespiratoryDiseases
5.2. Global Inhalable Drugs Market by Route of Administration
5.2.1. Nasal
5.2.2. Mouth
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. AptarGroup, Inc.
7.2. AstraZeneca Plc
7.3. Bausch Health Companies Inc.
7.4. Boehringer Ingelheim International GmbH
7.5. Cipla Ltd.
7.6. F. Hoffmann-La Roche Ltd.
7.7. GlaxoSmithKline Plc
7.8. Johnson & Johnson Services Inc.
7.9. Medisol Lifescience Pvt. Ltd.
7.10. Merck & Co., Inc.
7.11. Mylan NV
7.12. Novartis International AG
7.13. Pfizer Inc.
7.14. Sanofi SA
7.15. Sumitomo Dainippon Pharma Co. Ltd.
7.16. Teicos Pharma Ltd.
7.17. Teva Pharmaceutical Industries Ltd.
7.18. TFF Pharmaceuticals, Inc.
7.19. Vectura Group Plc
7.20. Verona Pharma plc
7.21. Zambon S.p.A.
List of Tables
1. GLOBAL INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
2. GLOBAL INHALABLE DRUGS FOR RESPIRATORY DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
3. GLOBAL INHALABLE DRUGS FOR NON-RESPIRATORY DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
4. GLOBAL INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
5. GLOBAL NASAL INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
6. GLOBAL MOUTH INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
7. GLOBAL INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
8. NORTH AMERICAN INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
9. NORTH AMERICAN INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
10. NORTH AMERICAN INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
1
List of Tables
1. EUROPEAN INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
12. EUROPEAN INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
13. EUROPEAN INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
14. ASIA-PACIFIC INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
15. ASIA-PACIFIC INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
16. ASIA-PACIFIC INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
17. REST OF THE WORLD INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
18. REST OF THE WORLD INHALABLE DRUGS MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
Related Report
